CRISIL is the famous Corporate Investor, which was founded in 1987. The leading representative office of defined Corporate Investor is situated in the Mumbai. The venture was found in Asia in India.
The top amount of exits for fund were in 2013. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2017.
Among the most successful fund investment fields, there are Risk Management, Information Technology. For fund there is a match between the location of its establishment and the land of its numerous investments - India. Besides, a startup needs to be aged more than 20 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline CARE Ratings
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the CRISIL, startups are often financed by Ascent Capital.
Related Funds
Fund Name | Location |
Aetna | Connecticut, Hartford, United States |
Ascendiant Capital Partners | California, Irvine, United States |
Beijing Xinglian Guanggao Youxian Gongsi | Beijing, Beijing, China |
Gabriel Investments | Pennsylvania, Philadelphia, United States |
Huiying Investment | China, Shaanxi, Xian Shi |
Inabata | Japan, Osaka, Osaka Prefecture |
Jiawei | China, Guangdong, Shenzhen |
Jicheng Chuangtou | China, Hangzhou, Zhejiang |
Kipo | Guatemala, Guatemala City |
Maven 11 Capital | Amsterdam, Noord-Holland, The Netherlands |
Multiplier Capital | New York, New York, United States |
N.XT Northwestern University | Evanston, Illinois, United States |
OOE Hightechfonds GmbH | Austria, Linz, Oberosterreich |
Reimann Investors | Bayern, Germany, München |
Synergy Capital Partners | Medina, Ohio, United States |
The Harry and Jeanette Weinberg Foundation | Maryland, Owings Mills, United States |
The Todd & Rahul Angel Fund | - |
THINK | China, Wenzhou, Zhejiang |
Yizhuang Biomedical Mergers and Acquisition Funds | China, Jiangsu, Yizhuang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.